As outbreaks of preventable diseases such as whooping cough and measles increase in the United States, researchers from the Regenstrief Institute and Indiana University School of Medicine are investigating whether altruism, known to influence adults' decisions to immunize themselves, influences parental decisions to vaccinate their children.
"If enough people are immunized against a particular disease, it prevents outbreaks of that disease and protects the community. This is known as herd immunity, and it's a very important benefit of childhood immunization," says Regenstrief Institute affiliated scientist S. Maria Finnell, MD, MS, IU School of Medicine assistant professor of pediatrics. "But as we are seeing more vaccine-hesitant parents, we need to better understand the factors that influence parents' decisions to immunize their children so that pediatricians can effectively communicate to them the importance of the recommended shots."
Â
As a first step in their investigation, the researchers, led by Finnell, conducted a systematic evidence-based analysis of peer-reviewed studies on parental decision-making regarding child immunization and found no study designed with the primary focus on "benefit to others" as a motivating factor. Their findings are reported in "The Role of Herd Immunity in Parents' Decision to Vaccinate Children: A Systematic Review," published in the September issue of Pediatrics, the official peer-reviewed journal of the American Academy of Pediatrics.
"Studies have shown that benefit to others is an effective motivator for adults to vaccinate themselves," says Regenstrief Institute investigator Stephen M. Downs, MD, MS, associate professor of pediatrics and director of Children's Health Services Research at the IU School of Medicine. "However, our review determined that it is not known whether the role of herd immunity -- immunizing to benefit the community -- plays a role in parents' decision regarding immunizing their children."
Now that they have reviewed the medical literature and found it inconclusive, Finnell and Downs and their co-investigators are completing a study to determine whether varying how immunization messages are framed influences vaccine-hesitant parents.
In addition to Finnell and Downs, authors of the Pediatrics paper, for which there was no external funding, are Maheen Quadri-Sheriff, MD, a former IU School of Medicine pediatrics resident, and Kristin S. Hendrix, PhD, Lynne A. Sturm, PhD, and Gregory D. Zimet, PhD, of the IU School of Medicine.
Sources: Regenstrief Institute and Indiana University School of Medicine
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.